Proportion of patients with residual disease across each LDA definition at Week 24.
| Variables | MDA 5/7 | MDA Skin | MDA Joint | MDA Joint + Skin | DAPSA LDA | cDAPSA LDA |
|---|---|---|---|---|---|---|
| Dactylitis (1–12) | 8/300 (2.7) | 5/129 (3.9) | 5/247 (2.0) | 3/97 (3.1) | 20/466 (4.3) | 19/469 (4.1) |
| Enthesitis (1–5) | 2/302 (0.7) | 2/130 (1.5) | 1/248 (0.4) | 1/97 (1.0) | 16/468 (3.4) | 16/471 (3.4) |
| PASI score 0 | 83/302 (27.5) | 82/130 (63.1) | 63/248 (25.4) | 63/97 (64.9) | 100/468 (21.4) | 100/471 (21.2) |
| PASI score 1 | 76/302 (25.2) | 48/130 (36.9) | 58/248 (23.4) | 34/97 (35.1) | 96/468 (20.5) | 100/471 (21.2) |
| PASI score 2–9 | 130/302 (43.0) | 0/130 (0.0) | 116/248 (46.8) | 0/97 (0.0) | 234/468 (50.0) | 232/471 (49.2) |
| PASI score ≥ 10 | 13/302 (4.3) | 0/130 (0.0) | 11/248 (4.4) | 0/97 (0.0) | 38/468 (8.1) | 39/471 (8.3) |
| TJC > 1 | 43/302 (14.2) | 28/130 (21.5) | 0/248 (0.0) | 0/97 (0.0) | 137/468 (29.3) | 135/471 (28.7) |
| SJC > 1 | 17/302 (5.6) | 14/130 (10.8) | 0/248 (0.0) | 0/97 (0.0) | 64/468 (13.7) | 62/471 (13.2) |
Values are n/N (%). LDA: low disease activity; MDA: minimal disease activity; DAPSA: Disease Activity for Psoriatic Arthritis; cDAPSA: clinical DAPSA; PASI: Psoriasis Area and Severity Index; TJC: tender joint count; SJC: swollen joint count.